BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ekmark-Lewén S, Lindström V, Gumucio A, Ihse E, Behere A, Kahle PJ, Nordström E, Eriksson M, Erlandsson A, Bergström J, Ingelsson M. Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice. Brain Behav 2018;8:e00915. [PMID: 29541535 DOI: 10.1002/brb3.915] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Aniszewska A, Bergström J, Ingelsson M, Ekmark-Lewén S. Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice. Brain Behav 2022;:e2628. [PMID: 35652155 DOI: 10.1002/brb3.2628] [Reference Citation Analysis]
2 Song B, Feldmann JW, Cao S, Feitosa M, Kong Y, Kim W, Schweitzer A, Leblanc P, Schweitzer JS, Kim K. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105777] [Reference Citation Analysis]
3 Roshanbin S, Xiong M, Hultqvist G, Söderberg L, Zachrisson O, Meier S, Ekmark-Lewén S, Bergström J, Ingelsson M, Sehlin D, Syvänen S. In vivo imaging of alpha-synuclein with antibody-based PET. Neuropharmacology 2022;:108985. [PMID: 35149134 DOI: 10.1016/j.neuropharm.2022.108985] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Klonarakis M, De Vos M, Woo E, Ralph L, Thacker JS, Gil-mohapel J. The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Veys L, Devroye J, Lefevere E, Cools L, Vandenabeele M, De Groef L. Characterizing the Retinal Phenotype of the Thy1-h[A30P]α-syn Mouse Model of Parkinson's Disease. Front Neurosci 2021;15:726476. [PMID: 34557068 DOI: 10.3389/fnins.2021.726476] [Reference Citation Analysis]
6 Behere A, Thörnqvist PO, Winberg S, Ingelsson M, Bergström J, Ekmark-Lewén S. Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model. J Neurosci Res 2021. [PMID: 34292621 DOI: 10.1002/jnr.24927] [Reference Citation Analysis]
7 Gentzel RC, Toolan D, Jinn S, Schachter JB, Ma L, Kahle PJ, Smith SM, Marcus JN. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction. Neurobiol Aging 2021;106:12-25. [PMID: 34225000 DOI: 10.1016/j.neurobiolaging.2021.05.012] [Reference Citation Analysis]
8 Fauser M, Pan-Montojo F, Richter C, Kahle PJ, Schwarz SC, Schwarz J, Storch A, Hermann A. Chronic-Progressive Dopaminergic Deficiency Does Not Induce Midbrain Neurogenesis. Cells 2021;10:775. [PMID: 33807497 DOI: 10.3390/cells10040775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Reyes JF, Ekmark-Léwen S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, Nilsson P, Nilsson KPR, Alafuzoff I, Ingelsson M, Hallbeck M. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease. Acta Neuropathol Commun 2021;9:46. [PMID: 33743820 DOI: 10.1186/s40478-021-01136-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tweedy C, Kindred N, Curry J, Williams C, Taylor JP, Atkinson P, Randall F, Erskine D, Morris CM, Reeve AK, Clowry GJ, LeBeau FEN. Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein. Neurobiol Dis 2021;149:105226. [PMID: 33347975 DOI: 10.1016/j.nbd.2020.105226] [Reference Citation Analysis]
11 Pingale T, Gupta GL. Classic and evolving animal models in Parkinson's disease. Pharmacol Biochem Behav 2020;199:173060. [PMID: 33091373 DOI: 10.1016/j.pbb.2020.173060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Yshii LM, Manfiolli AO, Denadai-Souza A, Kinoshita PF, Gomes MD, Scavone C. Tumor necrosis factor receptor-associated factor 6 interaction with alpha-synuclein enhances cell death through the Nuclear Factor-kB pathway. IBRO Rep 2020;9:218-23. [PMID: 32984640 DOI: 10.1016/j.ibror.2020.08.005] [Reference Citation Analysis]
13 Ferreyra E, Pasquetta L, Ramirez A, Wille-bille A, Molina JC, Miranda-morales RS. Biparental care in C57BL/6J mice: effects on adolescent behavior and alcohol consumption. Psychopharmacology 2020;237:1841-50. [DOI: 10.1007/s00213-020-05501-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Keane PC, Hanson PS, Patterson L, Blain PG, Hepplewhite P, Khundakar AA, Judge SJ, Kahle PJ, LeBeau FEN, Morris CM. Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice. Neurosci Lett 2019;711:134437. [PMID: 31422098 DOI: 10.1016/j.neulet.2019.134437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Lundberg S, Högman C, Roman E. Adolescent Exploratory Strategies and Behavioral Types in the Multivariate Concentric Square FieldTM Test. Front Behav Neurosci 2019;13:41. [PMID: 30886574 DOI: 10.3389/fnbeh.2019.00041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
16 Almandoz-Gil L, Persson E, Lindström V, Ingelsson M, Erlandsson A, Bergström J. In Situ Proximity Ligation Assay Reveals Co-Localization of Alpha-Synuclein and SNARE Proteins in Murine Primary Neurons. Front Neurol 2018;9:180. [PMID: 29623065 DOI: 10.3389/fneur.2018.00180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]